MTOR and gastric carcinoma: Most of the genetic mutations in gastric carcinoma correlate with changes in biological signals, such as those in the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin pathway (PI3K/Akt/mTOR pathway) [6].